Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial

Michael J. Soileau, Jason Aldred, Kumar Budur, Nahome Fisseha, Victor SC Fung, Anna Jeong, Thomas Kimber, Kevin J. Klos, Irene Litvan, Daniel I. O’Neill, Weining Robieson, Meredith Spindler, David G. Standaert, Saritha Talapala, Eleni Okeanis Vaou, Hui Zheng, Maurizio Facheris, Robert A. Hauser